The closing price of Vera Therapeutics Inc (NASDAQ: VERA) was $45.94 for the day, down -4.57% from the previous closing price of $48.14. In other words, the price has decreased by -$2.20 from its previous closing price. On the day, 513817 shares were traded. VERA stock price reached its highest trading level at $49.42 during the session, while it also had its lowest trading level at $45.61.
Ratios:
Our analysis of VERA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.64 and its Current Ratio is at 6.64. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on January 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $26.
On December 18, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $29.Raymond James initiated its Outperform rating on December 18, 2023, with a $29 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 30 when Katabi Maha bought 161,290 shares for $31.00 per share. The transaction valued at 4,999,990 led to the insider holds 3,628,446 shares of the business.
COMMODORE CAPITAL LP sold 1,050,000 shares of VERA for $18,900,000 on Jan 10. The 10% Owner now owns 4,400,000 shares after completing the transaction at $18.00 per share. On Aug 21, another insider, Fordyce Marshall, who serves as the President and CEO of the company, sold 5,210 shares for $16.66 each. As a result, the insider received 86,779 and left with 243,361 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 2.47B and an Enterprise Value of 2.33B.
Stock Price History:
Over the past 52 weeks, VERA has reached a high of $50.69, while it has fallen to a 52-week low of $5.95. The 50-Day Moving Average of the stock is 27.51, while the 200-Day Moving Average is calculated to be 17.32.
Shares Statistics:
VERA traded an average of 1.12M shares per day over the past three months and 1.02M shares per day over the past ten days. A total of 53.71M shares are outstanding, with a floating share count of 34.55M. Insiders hold about 35.68% of the company’s shares, while institutions hold 61.47% stake in the company. Shares short for VERA as of Feb 15, 2024 were 6.77M with a Short Ratio of 6.06, compared to 6.05M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 12.60% and a Short% of Float of 15.77%.
Earnings Estimates
The firm’s stock currently is rated by 9 analysts. On average, analysts expect EPS of -$0.51 for the current quarter, with a high estimate of -$0.42 and a low estimate of -$0.58, while EPS last year was -$1.18. The consensus estimate for the next quarter is -$0.51, with high estimates of -$0.43 and low estimates of -$0.63.
Analysts are recommending an EPS of between -$2.06 and -$2.28 for the fiscal current year, implying an average EPS of -$2.19. EPS for the following year is -$2.15, with 9 analysts recommending between -$1.74 and -$2.77.
